Amitriptyline [tricyclic antidepressant (TCA)] therapy in MDD patients is associated with decreased TNFα (Hinze-Selch et al., 2000), whereas desipramine, increases IL-10 in MDD patients but does not affect pro-inflammatory cytokines (Roque et al., 2009). This evidence concerns the gene IL10 and major depressive disorder.